A no-deal Brexit will be detrimental to people with rare diseases

Posted on 14 December 2020

 

On 11 December, a letter was published in The Lancet highlighting the detrimental impact of a no-deal Brexit on rare disease patients in the UK. This letter is co-authored by Graham Slater and Beverley Power, two ERNICA patient representatives. The letter has a total of 73 signatories, 54 signatories from UK senior clinicians and researchers who are currently members of an ERN, as well as 19 signatories each representing a patient support group.

The University of Cambridge has also released an article on the subject: https://www.cam.ac.uk/research/news/no-deal-brexit-could-have-detrimental-impact-for-four-million-people-in-uk-living-with-a-rare